Cardiol Therapeutics (CRDL) Competitors C$1.97 -0.10 (-4.83%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock CRDL vs. PYR, NVO, DNA, TLRY, VBV, CUS, AIM, FRX, ITH, and IPAShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), and ImmunoPrecise Antibodies (IPA). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Dalradian Resources Tilray Brands VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals International Tower Hill Mines ImmunoPrecise Antibodies Cardiol Therapeutics (TSE:CRDL) and PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Do institutionals & insiders believe in CRDL or PYR? 11.4% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation and earnings, CRDL or PYR? PyroGenesis Canada Inc. (PYR.V) has higher revenue and earnings than Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.87PyroGenesis Canada Inc. (PYR.V)C$6.01M100.97-C$3.94M-C$0.03-154.00 Is CRDL or PYR more profitable? PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -195.07% -54.15% PyroGenesis Canada Inc. (PYR.V) N/A N/A N/A Does the media favor CRDL or PYR? In the previous week, Cardiol Therapeutics and Cardiol Therapeutics both had 1 articles in the media. Cardiol Therapeutics' average media sentiment score of 0.00 equaled PyroGenesis Canada Inc. (PYR.V)'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardiol Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada Inc. (PYR.V) 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPyroGenesis Canada Inc. (PYR.V) beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$163.47MC$2.14BC$5.53BC$6.19BDividend YieldN/A2.92%5.24%6.72%P/E Ratio-3.874.1527.1956.61Price / SalesN/A563.67414.391,138.71Price / Cash0.9810.3526.2183.29Price / Book13.1911.477.924.69Net Income-C$42.93MC$21.15BC$3.17BC$301.20M7 Day Performance6.49%1.60%2.18%1.65%1 Month Performance2.60%6.45%1.25%4.19%1 Year Performance-27.04%2.38%33.90%27.78% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$1.97-4.8%N/A-23.3%C$163.47MN/A-3.8720PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090News CoverageGap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640TLRYTilray BrandsN/AC$0.53+6.0%N/A-71.4%C$341.52MC$610.34M-1.282,650Gap UpVBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia2.461 of 5 starsC$2.82-0.7%C$4.00+41.8%+9.9%C$271.22MC$464.71M-3.4720Gap UpFRXFennec PharmaceuticalsN/AC$11.56+7.3%N/A+52.6%C$222.93MC$34.86M-195.8210Insider TradeGap DownHigh Trading VolumeITHInternational Tower Hill MinesN/AC$1.22+5.2%N/A+73.9%C$171.28MN/A-50.97220Gap UpIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap Down Related Companies and Tools Related Companies PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Dalradian Resources Alternatives Tilray Brands Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives International Tower Hill Mines Alternatives ImmunoPrecise Antibodies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRDL) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
